509 related articles for article (PubMed ID: 20299475)
1. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.
Houde VP; Brûlé S; Festuccia WT; Blanchard PG; Bellmann K; Deshaies Y; Marette A
Diabetes; 2010 Jun; 59(6):1338-48. PubMed ID: 20299475
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
Shum M; Bellmann K; St-Pierre P; Marette A
Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
[TBL] [Abstract][Full Text] [Related]
4. PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats.
Festuccia WT; Blanchard PG; Belchior T; Chimin P; Paschoal VA; Magdalon J; Hirabara SM; Simões D; St-Pierre P; Carpinelli A; Marette A; Deshaies Y
Am J Physiol Endocrinol Metab; 2014 May; 306(9):E1046-54. PubMed ID: 24619883
[TBL] [Abstract][Full Text] [Related]
5. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.
den Hartigh LJ; Goodspeed L; Wang SA; Kenerson HL; Omer M; O'Brien KD; Ladiges W; Yeung R; Subramanian S
Exp Physiol; 2018 Nov; 103(11):1469-1480. PubMed ID: 30117227
[TBL] [Abstract][Full Text] [Related]
6. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
[TBL] [Abstract][Full Text] [Related]
8. Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance.
Balage M; Dupont J; Mothe-Satney I; Tesseraud S; Mosoni L; Dardevet D
J Nutr Biochem; 2011 Mar; 22(3):219-26. PubMed ID: 20558053
[TBL] [Abstract][Full Text] [Related]
9. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
Khamzina L; Veilleux A; Bergeron S; Marette A
Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
[TBL] [Abstract][Full Text] [Related]
10. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
Fang P; Sun Y; Gu X; Shi M; Bo P; Zhang Z; Bu L
Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment.
Lopes PC; Fuhrmann A; Carvalho F; Sereno J; Santos MR; Pereira MJ; Eriksson JW; Reis F; Carvalho E
Biochem Pharmacol; 2014 Sep; 91(1):61-73. PubMed ID: 24960264
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin negatively impacts insulin signaling, glucose uptake and uncoupling protein-1 in brown adipocytes.
García-Casarrubios E; de Moura C; Arroba AI; Pescador N; Calderon-Dominguez M; Garcia L; Herrero L; Serra D; Cadenas S; Reis F; Carvalho E; Obregon MJ; Valverde ÁM
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1929-1941. PubMed ID: 27686967
[TBL] [Abstract][Full Text] [Related]
13. The Lou/C rat: a model of spontaneous food restriction associated with improved insulin sensitivity and decreased lipid storage in adipose tissue.
Veyrat-Durebex C; Montet X; Vinciguerra M; Gjinovci A; Meda P; Foti M; Rohner-Jeanrenaud F
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1120-32. PubMed ID: 19208855
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model.
Fuhrmann A; Lopes P; Sereno J; Pedro J; Espinoza DO; Pereira MJ; Reis F; Eriksson JW; Carvalho E
Biochem Pharmacol; 2014 Mar; 88(2):216-28. PubMed ID: 24462915
[TBL] [Abstract][Full Text] [Related]
15. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
16. Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.
Deblon N; Bourgoin L; Veyrat-Durebex C; Peyrou M; Vinciguerra M; Caillon A; Maeder C; Fournier M; Montet X; Rohner-Jeanrenaud F; Foti M
Br J Pharmacol; 2012 Apr; 165(7):2325-40. PubMed ID: 22014210
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver.
Miyake K; Ogawa W; Matsumoto M; Nakamura T; Sakaue H; Kasuga M
J Clin Invest; 2002 Nov; 110(10):1483-91. PubMed ID: 12438446
[TBL] [Abstract][Full Text] [Related]
18. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
19. Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats.
Rebollo A; Roglans N; Baena M; Padrosa A; Sánchez RM; Merlos M; Alegret M; Laguna JC
J Nutr Biochem; 2014 Feb; 25(2):250-8. PubMed ID: 24445051
[TBL] [Abstract][Full Text] [Related]
20. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
Adochio R; Leitner JW; Hedlund R; Draznin B
Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
